ProShare Advisors LLC Has $173.98 Million Stock Position in Cardinal Health, Inc. $CAH

ProShare Advisors LLC lowered its stake in Cardinal Health, Inc. (NYSE:CAH) by 9.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,108,450 shares of the company’s stock after selling 120,405 shares during the quarter. ProShare Advisors LLC owned about 0.47% of Cardinal Health worth $173,982,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. SJS Investment Consulting Inc. lifted its position in Cardinal Health by 1,363.6% in the 3rd quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock valued at $25,000 after acquiring an additional 150 shares in the last quarter. Jones Financial Companies Lllp raised its stake in shares of Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares during the period. Atlantic Edge Private Wealth Management LLC raised its stake in shares of Cardinal Health by 75.0% in the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock valued at $29,000 after purchasing an additional 75 shares during the period. American Capital Advisory LLC lifted its holdings in shares of Cardinal Health by 5,200.0% in the third quarter. American Capital Advisory LLC now owns 212 shares of the company’s stock valued at $33,000 after purchasing an additional 208 shares in the last quarter. Finally, Vermillion & White Wealth Management Group LLC boosted its position in shares of Cardinal Health by 55.0% during the second quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock worth $34,000 after buying an additional 71 shares during the period. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Down 0.1%

NYSE:CAH opened at $226.85 on Monday. The stock has a market capitalization of $53.38 billion, a PE ratio of 32.64, a P/E/G ratio of 1.48 and a beta of 0.64. Cardinal Health, Inc. has a 1-year low of $120.72 and a 1-year high of $230.81. The firm has a fifty day simple moving average of $206.92 and a 200 day simple moving average of $180.29.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, February 5th. The company reported $2.63 EPS for the quarter, beating analysts’ consensus estimates of $2.31 by $0.32. The firm had revenue of $65.63 billion during the quarter, compared to analysts’ expectations of $64.88 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 92.50%. The company’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same quarter last year, the company posted $1.93 earnings per share. On average, equities analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health News Summary

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Q2 results and raised outlook — Cardinal reported Q2 FY2026 revenue up ~19% to $65.6B and non‑GAAP EPS of $2.63 (beat), and raised fiscal‑year non‑GAAP EPS guidance to $10.15–$10.35; management cited strong specialty medicine demand and improved segment performance. PR Newswire
• Positive Sentiment: Analyst upgrade and price‑target lift — Leerink Partners raised its price target from $240 to $268 and kept an outperform rating, signaling more upside from current levels. MarketScreener
• Positive Sentiment: Street commentary and momentum coverage — Multiple outlets (Barron’s, Reuters, Zacks, TipRanks, 24/7 Wall St.) highlight the beat, raised guidance and accelerating specialty drug volumes, which has driven momentum interest in the stock. Examples: Reuters coverage on the outlook and Barron’s note on guidance lifts. Reuters
• Neutral Sentiment: Earnings call & transcripts available — Management commentary and slides from the Q2 call confirm the drivers behind the beat (specialty medicine, margin expansion, buybacks); these provide detail but no new surprises beyond the release. MSN Transcript
• Neutral Sentiment: Momentum stock analysis — Zacks highlights style‑score based momentum attributes, which can attract technical and quant funds but also increase volatility. Zacks
• Negative Sentiment: Valuation and historical ROE signal — After the rally the stock trades at an elevated P/E (~34x) and company data show a negative trailing return on equity metric, which could concern value‑focused investors and limit upside absent continued execution. Background valuation metrics

Analyst Upgrades and Downgrades

CAH has been the topic of a number of recent research reports. Citigroup raised Cardinal Health from a “neutral” rating to a “buy” rating and lifted their target price for the company from $190.00 to $244.00 in a research report on Friday, January 9th. Evercore reaffirmed an “outperform” rating and set a $260.00 price target on shares of Cardinal Health in a research note on Thursday. TD Cowen reiterated a “buy” rating on shares of Cardinal Health in a report on Tuesday, January 27th. Mizuho increased their target price on shares of Cardinal Health from $222.00 to $235.00 and gave the stock an “outperform” rating in a report on Friday. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday, January 21st. Fifteen investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $241.27.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.